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Abstract
Background
Tuberculosis (TB) case notification rates are usually higher in men than in women, but notifi-
cation data are insufficient to measure sex differences in disease burden. This review set
out to systematically investigate whether sex ratios in case notifications reflect differences
in disease prevalence and to identify gaps in access to and/or utilisation of diagnostic
services.
Methods and Findings
In accordance with the published protocol (CRD42015022163), TB prevalence surveys in
nationally representative and sub-national adult populations (age 15 y) in low- and mid-
dle-income countries published between 1 January 1993 and 15 March 2016 were identified
through searches of PubMed, Embase, Global Health, and the Cochrane Database of
Systematic Reviews; review of abstracts; and correspondence with the World Health Orga-
nization. Random-effects meta-analyses examined male-to-female (M:F) ratios in TB preva-
lence and prevalence-to-notification (P:N) ratios for smear-positive TB. Meta-regression
was done to identify factors associated with higher M:F ratios in prevalence and higher P:N
ratios. Eighty-three publications describing 88 surveys with over 3.1 million participants in
28 countries were identified (36 surveys in Africa, three in the Americas, four in the Eastern
Mediterranean, 28 in South-East Asia and 17 in the Western Pacific). Fifty-six surveys
reported in 53 publications were included in quantitative analyses. Overall random-effects
weighted M:F prevalence ratios were 2.21 (95% CI 1.92–2.54; 56 surveys) for bacteriologi-
cally positive TB and 2.51 (95% CI 2.07–3.04; 40 surveys) for smear-positive TB. M:F
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prevalence ratios were highest in South-East Asia and in surveys that did not require self-
report of signs/symptoms in initial screening procedures. The summary random-effects
weighted M:F ratio for P:N ratios was 1.55 (95% CI 1.25–1.91; 34 surveys). We intended to
stratify the analyses by age, HIV status, and rural or urban setting; however, few studies
reported such data.
Conclusions
TB prevalence is significantly higher among men than women in low- and middle-income
countries, with strong evidence that men are disadvantaged in seeking and/or accessing
TB care in many settings. Global strategies and national TB programmes should recognise
men as an underserved high-risk group and improve men’s access to diagnostic and
screening services to reduce the overall burden of TB more effectively and ensure gender
equity in TB care.
Author Summary
WhyWas This Study Done?
• Global health initiatives have tended to treat “gender” issues in health as being synony-
mous with women’s health. However, for infectious diseases, policy and practice need to
be guided by epidemiological data and consideration of transmission dynamics.
• Many more men than women are diagnosed with, and die from, tuberculosis (TB) globally.
• Data from population-level surveys for undiagnosed TB, carried out in a number of coun-
tries during the last two decades, can be combined with data on diagnosed (notified) cases
to provide more complete insight into the magnitude and nature of sex differences in TB.
What Did the Researchers Do and Find?
• Surveys conducted to identify adult cases of TB in communities in low- and middle-
income countries between 1993 and 2016 were analysed by sex.
• TB prevalence among men was over twice as high as among women and was substan-
tially higher even in settings with high HIV prevalence.
• Case notification rates were also higher for men, and the ratio of prevalent-to-notified
cases of TB—an indication of how long patients take to be diagnosed, on average—was
1.5 times higher among men than women, suggesting that men are less likely than
women to achieve a timely diagnosis.
What Do These Findings Mean?
• Given that undiagnosed TB is the key driver for transmission in communities, our data
show that greater effort and investment are needed to improve awareness of TB in men
as an individual and public health issue.
Sex differences in TB prevalence
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• Policies on gender and TB should place greater emphasis on the high burden of disease
in men and the need to invest in male-friendly diagnostic and screening services, with
the aim of reducing undiagnosed TB.
Introduction
Over the past twenty years, tuberculosis (TB) case notifications among men have exceeded
those among women in most settings [1]. In 2014, the male-to-female (M:F) ratio in smear-
positive pulmonary TB case notification was 1.7 globally and ranged from 1.0 in the Eastern
Mediterranean Region to 2.1 in the Western Pacific Region [2]. The excess of notified cases
among men has often been explained as a result of barriers faced by women in seeking care for
and being diagnosed with TB [3,4]. However, notification data alone are insufficient to deter-
mine whether this is true, or whether sex differences in case notifications reflect an excess in
the burden of disease among men and even a disadvantage among men in seeking and access-
ing TB care.
Prevalence surveys offer a robust measure of disease burden in the community, reducing or
eliminating the care-seeking biases that affect case notifications: a higher proportion of men in
case notifications could reflect either higher incidence of TB disease or more complete registra-
tion for treatment by men. Prevalence surveys predominantly identify infectious TB patients
with previously undiagnosed TB disease who have, therefore, not contributed to routine notifi-
cation data before participation in the survey. As such, comparison of the characteristics of
diagnosed TB patients (notification data) with those of undiagnosed TB patients (prevalence
survey data) provides a unique insight into diagnosis and treatment access barriers. For exam-
ple, finding a similar male predominance in undiagnosed TB (prevalence surveys) patients as
in notified TB cases would support the hypothesis that men genuinely have a higher burden of
TB disease, while finding a greater male predominance in undiagnosed TB patients than in
notified TB cases would suggest male-specific access barriers or male sex being a risk factor for
TB disease.
A previous analysis in 2000 found that male TB prevalence exceeded female TB prevalence
in 27 (93%) of 29 prevalence surveys conducted in 14 countries between 1953 and 1997 [5].
The same analysis calculated the patient diagnostic rate (the inverse of the prevalence-to-notifi-
cation ratio) and found that female cases were more likely to be notified than male cases in 21
(72%) surveys.
Despite these findings, men are often overlooked in discussions of gender and TB. While
global TB reports and meetings on gender acknowledge the fact that the majority of TB cases
and TB-associated deaths occur among men, greater focus is usually placed on women. More
broadly in global health discussions, there is a tendency to use the word “gender” when really
“women” is meant, as exemplified by the Millennium Development Goals [6] and Sustainable
Development Goals [7]. Subsequently, an emphasis on men runs contrary to global norms [8],
and strategies to assess and address men’s barriers to TB care are notably absent from the
global research agenda.
The World Health Organization’s End TB Strategy emphasises the importance of equity in
access to diagnosis and treatment [9]; men should not be excluded from this target. The End
TB Strategy has also prioritised systematic screening of high-risk groups to ensure early diag-
nosis of individuals with TB [10]. If TB prevalence remains higher among men than women, as
Sex differences in TB prevalence
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in previous analysis [5], men should be considered a high-risk group for TB [11], and national
TB programmes should more actively target men with routine diagnostic and/or screening ser-
vices. This action is necessary to reduce the burden of TB in the whole population more effec-
tively [12] and to ensure that principles of gender equity are upheld.
This review set out to systematically investigate sex differences in the prevalence of bacterio-
logically positive TB and smear-positive TB in adult participants in cross-sectional surveys
conducted in low- and middle-income countries to determine whether sex ratios in adult case
notifications reflect population sex differences in disease and to compare prevalence-to-notifi-
cation (P:N) ratios for men and women. The current study adds to previous analysis [5] by
including surveys conducted since the widespread availability of anti-TB chemotherapy in low-
resource settings and the implementation of the directly observed treatment short course
(DOTS) strategy, as well as the rise of the HIV/AIDS pandemic and the implementation of
interventions against it—all factors that may have different effects on TB in men and women.
The current study also provides more detailed meta-analyses of sex differences in TB preva-
lence and P:N ratios.
Methods
Search Strategy
In accordance with the published protocol [13], studies describing national and sub-national
TB prevalence surveys in adult populations (age 15 y) in low- and middle-income countries
published between 1 January 1993 and 15 March 2016 were identified through searches of
PubMed, Embase, Global Health, and the Cochrane Database of Systematic Reviews (Table 1).
TheWHO Global Tuberculosis Report 2015 [2] and abstract books from the UnionWorld Con-
ference on Lung Health (2012–2015) were also searched by hand, as were the reference lists of
included studies. Researchers in the field and at WHO were contacted to assist with identifica-
tion of relevant studies.
Two authors (K. C. H. and P. M.) independently reviewed titles and abstracts in parallel to
identify relevant studies for full-text review. A third author (E. L. C.) resolved any discrepan-
cies. The same authors reviewed full texts to determine whether studies met inclusion criteria
and then extracted data on study methodology and TB prevalence in parallel using piloted elec-
tronic forms.
Study authors were contacted for additional information if studies did not report the num-
ber of participants and the number of bacteriologically positive and/or smear-positive TB cases
Table 1. Search strategy.
Set Search Algorithm
PubMed Embase/Global Health Cochrane Library
1 ((“tuberculosis”[MeSH terms] OR “tuberculosis”OR “Tuberculoses”)
OR (“Mycobacterium tuberculosis”[MeSH terms])) NOT
((“animals”[MeSH terms] NOT (“humans”[MeSH terms] AND
“animals”[MeSH terms])))
((tuberculos* or Mycobacterium
tuberculosis) NOT (animals not (humans
and animals))).hw,ti.
(tuberculos* or
“Mycobacterium tuberculosis”):
ti,kw
2 (cross-sectional[MeSH terms] OR mass screening[MeSH terms] OR
prevalence[MeSH terms] OR (prevalence[tw] AND study[tw]) OR
(prevalence[tw] AND studies[tw]))
(cross-sectional or mass screening or
prevalence).hw,ti.
(cross-sectional or “mass
screening” or prevalence):ti,kw
3 Cochrane LMIC search terms [14] Cochrane LMIC search terms [14] Cochrane LMIC search terms
[14]
4 “1993/01/01”[Date—Publication]: “3000”[Date—Publication] 1 and 2 and 3 (#1 AND #2 AND #3)
5 English [la] Limit 4 to time period from 1993–present Limit 4 to time period 1993–
present
6 1 AND 2 AND 3 AND 4 AND 5 Limit 5 to English language
doi:10.1371/journal.pmed.1002119.t001
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by sex for adult participants. Authors were also contacted if sex-specific prevalence data were
not available by age group.
Inclusion and Exclusion Criteria
The review included cross-sectional prevalence surveys conducted in low- and middle-income
countries [15]. Studies conducted among symptomatic or care-seeking individuals, children,
individuals of a single sex, occupational settings, or other sub-populations (e.g., only HIV-posi-
tive individuals) were excluded. Studies reporting prevalence ofMycobacterium tuberculosis
infection but not TB disease were excluded. Individuals under 15 y of age were excluded since
diagnosis of childhood TB is more complicated than diagnosis of adult disease, especially
within the context of community-based surveys [16]. Studies including both adults and chil-
dren were included in the qualitative review but were excluded from quantitative analyses
unless the study reported participation and prevalence for adults. Studies published in lan-
guages other than English were excluded due to limited resources for translation. Where more
than one report was identified for a single survey, the most complete source was included and
the others were excluded.
Study Quality
The risk of bias in included studies was assessed in parallel by K. C. H. and P. M. Each study
was ranked on eight criteria from a tool developed to assess the risk of bias in prevalence sur-
veys [17]. These criteria assessed factors related to the selection of the study population, the
risk of nonresponse bias, data collection methods, and case definitions. The eight criteria were
summarised to give an assessment of the overall risk of bias.
Definitions
Study participants were defined as individuals who were interviewed and/or underwent initial
screening procedures, according to study-specific procedures. Participation was defined as the
number of participants divided by the number of individuals who were eligible or invited to
participate. High relative male participation was defined as a M:F ratio in participation 0.90.
Case definitions for TB were based on internationally recognised terminology, where avail-
able, and study-specific definitions otherwise. Bacteriologically positive TB was defined as posi-
tive smear microscopy, culture, or WHO-approved rapid diagnostic results (such as from
Xpert MTB/RIF) [18].
Sex-specific prevalence of bacteriologically and smear-positive TB was defined as the num-
ber of individuals with bacteriologically or smear-positive TB divided by the number of study
participants, by sex. Reported prevalence was used to estimate the number of cases or the num-
ber of participants where one of these values was missing. No adjustments were made for non-
participation or nonsampling.
Sex-specific P:N ratios were calculated as the ratio of smear-positive TB prevalence per
100,000 individuals to smear-positive TB case notifications per 100,000 individuals among
adults [5,19]. WHO case notification data [20] and United Nations population estimates [21]
were matched to each prevalence survey by country and year. For surveys that took place over
more than one calendar year, the annual case notification rate was averaged over all survey
years (excluding years with no reported data). No adjustments were made for sub-national
surveys.
National estimates of TB and HIV burden were matched to each prevalence survey by coun-
try and year. For surveys that took place over more than one calendar year, estimates were
averaged over all survey years (excluding years with no reported data). High TB prevalence was
Sex differences in TB prevalence
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defined using the median value for included studies, which was an estimated national TB
prevalence 300 per 100,000 individuals [22]. High HIV prevalence was defined as estimated
national HIV prevalence 1% in the general population [23,24], and high HIV prevalence in
incident TB was defined as estimated HIV prevalence 20% in new and relapse TB cases
[22,25].
Data Analysis
Prevalence of bacteriologically positive TB and smear-positive TB was calculated for included
studies by sex. Prevalence of bacteriologically positive TB by sex and age was also calculated,
where possible. Sub-group prevalence was estimated for sub-groups based on survey character-
istics including WHO geographical region, survey setting (national versus sub-national),
national estimates of TB and HIV burden (both in the general population; the latter also in
incident TB), study quality, initial screening procedures, case definitions, and relative male par-
ticipation. Clopper-Pearson confidence intervals [26] and M:F ratios were calculated for all
prevalence estimates. P:N ratios for smear-positive TB were estimated with confidence inter-
vals based on the estimated variance using a continuity correction of 0.5 in the corresponding
prevalence estimates.
Heterogeneity was assessed using the I2 statistic [27]. Due to substantial heterogeneity
between studies, random-effects models were used for meta-analyses, weighting for the inverse
of the variance. Random-effects weighted summary M:F ratios were calculated for participa-
tion, prevalence of bacteriologically positive TB and smear-positive TB, age-specific prevalence
of bacteriologically positive TB, and P:N ratios.
Meta-regression was performed for M:F ratios in prevalence and M:F ratios in P:N ratios to
examine associations with the survey characteristics mentioned above, plus the starting year of
each survey. Univariate meta-regression of M:F ratios in prevalence was conducted separately
for bacteriologically positive TB and smear-positive TB. If either univariate meta-regression
suggested evidence of an association with a particular characteristic, that characteristic was
included as a variable in the multivariate meta-regression models for both bacteriologically
positive and smear-positive TB. Similarly, multivariate meta-regression of M:F ratios in P:N
ratios was based on evidence of associations in univariate analysis.
All analyses were performed using R version 3.2.2 [28] (S1 Data; S1 Analysis).
Results
Study Characteristics
Of 7,502 potentially relevant English-language studies screened by title and abstract, 148 were
reviewed in full; of these, 65 were excluded after full-text review (S1 Table) and 83 were eligible for
inclusion (Fig 1; S2 Table) [29–111]. Included studies describe 88 surveys in 28 countries: 36 sur-
veys in 13 countries in the African Region, three surveys in two countries in the Region of the
Americas, four surveys in two countries in the Eastern Mediterranean Region, 28 surveys in five
countries in the South-East Asia Region, and 17 surveys in six countries in theWestern Pacific
Region (Fig 2). There were 22 nationally representative surveys and 66 sub-national surveys, with at
least 20 of the latter conducted in urban settings and eight among tribal populations. Over 3.1 mil-
lion adult participants were included; 16 surveys did not report the number of adult participants.
Study Quality
The risk of bias assessment identified 33 (43%) surveys with low risk of bias, 32 (42%) with
moderate risk of bias, and 12 (16%) with high risk of bias (S1 Fig). Eleven surveys for which
Sex differences in TB prevalence
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Fig 1. PRISMA flow diagram.Mtb, Mycobacterium tuberculosis.
doi:10.1371/journal.pmed.1002119.g001
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only an abstract was available were characterised as unknown risk of bias due to limited infor-
mation on study methodology [34,54,57,62,63,75,76,79,80,95,104]. The quantitative analyses
included a slightly higher proportion of surveys with low risk of bias than the qualitative sum-
mary. In all, 84% to 94% of the surveys in the quantitative analyses had low to moderate risk of
bias (S2 Fig).
Participation by Sex
Female participation equalled or exceeded male participation in all of the 28 surveys for which
participation was reported by sex (Fig 3). Of 687,926 men eligible or invited to participate,
521,934 (75.9%) participated, while 611,901 (82.5%) of 741,705 eligible or invited women par-
ticipated. The overall random-effects weighted M:F ratio in participation was 0.90 (95% CI
0.86–0.93; range 0.50 to 1.00).
TB Prevalence by Sex
The prevalence of bacteriologically positive TB was reported by sex in 56 surveys with 2.2 million
participants in 24 countries [29,30,32,33,35,36,38–44,47–51,53,55,56,58–60,65–67,69–74,82,84,
85,87,89–94,97,101,102,104,105,107,110–112]. Forty surveys with 1.7 million participants in 22
countries reported the prevalence of smear-positive TB by sex [35,40,43,44,48–51,53,55,56,58–
60,65–67,69–71,73,74,85,87,89,90,92,94,97,101,102,105,107,110,111]. The overall random-effects
weighted prevalence per 100,000 individuals was 488 (95% CI 382–623) among men and 231
(95% CI 166–321) among women for bacteriologically positive TB and 314 (95% CI 245–403)
among men and 129 (95% CI 89–189) among women for smear-positive TB (S3 Table).
Fig 2. Global map showing countries in which prevalence surveys have been conducted. Yellow indicates low- and middle-income countries for
which sex-disaggregated data are available from at least one prevalence survey (n = 24). Red indicates low- and middle-income countries in which at least
one prevalence survey has been conducted but sex-disaggregated data are not available (n = 4). Dark gray indicates low- and middle-income countries
where no prevalence survey has been identified (n = 107). Labels show the total number of surveys identified within each country for which at least one
prevalence survey was identified (n = 88).
doi:10.1371/journal.pmed.1002119.g002
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Excluding the Region of the Americas—because it had only two small sub-national surveys
included in the quantitative analysis—the prevalence of bacteriologically positive TB and
smear-positive TB was highest in the African Region. There was strong evidence that male and
female prevalence of bacteriologically positive TB per 100,000 individuals was higher in set-
tings with high HIV prevalence in the general population (high versus low HIV prevalence set-
tings: for men, 1,162, 95% CI 735–1,834, versus 360, 95% CI 275–471, p< 0.001; for women,
735, 95% CI 448–1202, versus 157, 95% CI 110–223, p< 0.001). This same relationship (higher
prevalence of undiagnosed TB in settings with high HIV prevalence) was also apparent when
HIV data from diagnosed TB patients, rather than the general population, were used (for men:
907, 95% CI 582–1,413, versus 359, 95% CI 270–477, p = 0.001; for women: 553, 95% CI 341–
896, versus 153, 95% CI 105–224, p< 0.001) (S4 Table). Prevalence of smear-positive TB per
100,000 individuals was also higher in settings with high HIV prevalence in the general popula-
tion (high versus low HIV prevalence settings: for men, 548, 95% CI 303–990, versus 275, 95%
CI 208–364, p = 0.039; for women, 273, 95% CI 131–568, versus 110, 95% CI 71–169, p =
0.036) and in settings with high HIV prevalence in diagnosed TB patients for women (229,
95% CI 126–416, versus 103, 95% CI 64–165, p = 0.040) but not for men (459, 95% CI 289–
727, versus 270, 95% CI 200–366, p = 0.060) (S4 Table).
Fig 3. Male-to-female ratios of participation among eligible or invited individuals (n = 29). Analysis includes surveys that report
the number of individuals who were eligible for screening and the number of individuals screened by sex. See S2 Table for survey
details and references. Lao PDR, Lao People’s Democratic Republic.
doi:10.1371/journal.pmed.1002119.g003
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Male-to Female Ratios in TB Prevalence
The overall random-effects weighted M:F prevalence ratio was 2.21 for bacteriologically posi-
tive TB (95% CI 1.92–2.54; range 0.62 to 6.18; 56 surveys in 24 countries) and 2.51 for smear-
positive TB (95% CI 2.07–3.04; range 0.25 to 5.91; 40 surveys in 22 countries). Random-effects
weighted M:F prevalence ratios for bacteriologically positive TB and smear-positive TB were
significantly greater than one in all regions except the Region of the Americas, where analyses
included only two small sub-national surveys (Fig 4).
Among countries with multiple surveys, an excess of male TB cases was observed in all stud-
ies in eight (73%) of 11 countries. Exceptions with inconsistent results were Ethiopia, South
Africa, and Viet Nam, although overall random-effects weighted M:F prevalence ratios
exceeded one for each of these countries.
Univariate Meta-regression of Male-to-Female Ratios in Prevalence
In univariate meta-regression of M:F ratios in bacteriologically positive TB (Table 2), there was
strong evidence that M:F prevalence ratios were 1.95 times higher in the South-East Asia
Region than in the African Region (95% CI 1.54–2.48; 56 surveys). M:F prevalence ratios were
lower in settings with high HIV prevalence in the general population (0.67, 95% CI 0.49–0.90;
54 surveys) or in incident TB (0.69, 95% CI 0.53–0.93; 54 surveys).
M:F prevalence ratios were also higher in the South-East Asia Region than in the African
Region in univariate meta-regression of smear-positive TB (1.91, 95% CI 1.33–2.75; 39 sur-
veys). In this analysis there was also evidence that M:F prevalence ratios were lower in surveys
that required individuals to report signs or symptoms of TB during initial screening procedures
(0.63, 95% CI 0.42–0.96; 39 surveys) compared to surveys within which initial screening proce-
dures included criteria such as chest X-ray, self-reported history of TB, or self-reported contact
with a TB case, instead of or in addition to self-reported signs or symptoms.
In univariate meta-regression models for M:F ratios in bacteriologically positive TB and M:
F ratios in smear-positive TB, none of the following survey characteristics were associated with
differences in M:F ratios in TB prevalence: survey setting (national versus sub-national), survey
starting year, TB prevalence, risk of bias, case definitions, or relative sex ratios in participation.
Multivariate Meta-regression of Male-to-Female Ratios in Prevalence
In multivariate meta-regression of M:F ratios in bacteriologically positive TB, there was evi-
dence that M:F ratios remained higher in the South-East Asia Region than in the African
Region after adjusting for HIV prevalence and initial screening procedures, although the rela-
tive M:F ratio between these two regions was slightly lower than in univariate analysis (1.78,
95% CI 1.13–2.80; 54 surveys).
There was evidence in the multivariate meta-regression of M:F ratios in smear-positive TB
that M:F ratios were 2.21 times higher in the South-East Asia Region than in the African region
(95% CI 1.23–4.04; 38 surveys). There was also evidence in the multivariate meta-regression
that M:F ratios in surveys that required individuals to self-report signs or symptoms of TB in
initial screening procedures were lower than those in surveys with broader initial screening
procedures (0.65, 95% CI 0.45–0.93; 38 surveys).
TB Prevalence by Sex and Age
Data on the prevalence of bacteriologically positive TB by sex and age were available for 19 sur-
veys in 13 countries [32,33,35,36,43,44,50,51,53,58,60,65–67,70,71,97,101,107]. Random-
effects weighted M:F ratios in prevalence appear to increase with age from 1.28 (95% CI 0.85–
Sex differences in TB prevalence
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Fig 4. Male-to-female ratios in bacteriologically positive (n = 56) and smear-positive (n = 40) TB prevalence byWHO region.Regional and
overall summaries from random-effects models for bacteriologically positive and smear-positive TB. See S2 Table for survey details and references.
Lao PDR, Lao People’s Democratic Republic.
doi:10.1371/journal.pmed.1002119.g004
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1.92; range 0.29 to 5.06) among individuals aged 15–24 y to 3.18 (95% CI 2.24–4.53; range 0.57
to 11.34) among individuals aged 45–54 y (Fig 5).
Prevalence-to-Notification Ratios by Sex
P:N ratios for smear-positive TB exceeded one for both men and women in 25 (74%) of 34 sur-
veys in 20 countries with available data (Fig 6). The median number of prevalent cases per noti-
fied case was 2.6 (interquartile range 1.3–3.4) for men and 1.6 (interquartile range 1.2–2.7) for
women, and the overall random-effects weighted M:F ratio for P:N ratios was 1.55 (95% CI
1.25–1.91).
Univariate Meta-regression for Male-to-Female Ratios in Prevalence-to-
Notification Ratios
There was no evidence in univariate meta-regression that any of the study or setting character-
istics examined were associated with M:F ratios in P:N ratios (S5 Table). Due to the lack of evi-
dence of associations in univariate analyses, multivariate meta-regression was not performed
for M:F ratios in P:N ratios.
Table 2. Univariate andmultivariate random-effects meta-regression results for male-to-female ratios in bacteriologically positive TB and smear-
positive TB.
Analysis Bacteriologically Positive TB Smear-Positive TB
N Relative M:F Ratio
(95% CI)
p-Value N Relative M:F Ratio (95%
CI)
p-Value
Univariate analysis
AMR versus AFR 56 0.45 (0.21–0.99) 0.047 39 0.34 (0.13–0.89) 0.029
EMR versus AFR 0.89 (0.51–1.56) 0.692 n/a
SEAR versus AFR 1.95 (1.54–2.48) <0.001 1.91 (1.33–2.75) <0.001
WPR versus AFR 1.17 (0.87–1.59) 0.302 1.05 (0.68–1.61) 0.838
National versus sub-national 56 1.01 (0.75–1.37) 0.927 39 1.11 (0.74–1.67) 0.610
Survey starting year 54 0.99 (0.96–1.03) 0.697 38 1.00 (0.96–1.05) 0.976
High versus low TB prevalence 54 0.97 (0.72–1.32) 0.864 38 1.12 (0.73–1.70) 0.605
High versus low HIV prevalence in general population 54 0.67 (0.49–0.90) 0.008 38 0.78 (0.47–1.29) 0.334
High versus low HIV prevalence in incident TB 54 0.69 (0.52–0.93) 0.014 38 0.77 (0.49–1.21) 0.254
Low versus moderate/high risk of bias 55 0.85 (0.63–1.10) 0.266 39 1.07 (0.71–1.63) 0.739
Initial screening procedures requiring self-report of signs/symptoms
versus broader initial screening procedures
56 0.80 (0.58–1.10) 0.170 39 0.63 (0.42–0.96) 0.031
Diagnosis by smear microscopy versus other diagnostic measures 53 0.93 (0.68–1.28) 0.660 36 0.72 (0.45–1.14) 0.159
Low versus high relative male participation 29 0.89 (0.60–1.32) 0.553 22 0.93 (0.53–1.62) 0.789
Multivariate analysis
AMR versus AFR 54 0.46 (0.19–1.10) 0.080 38 0.53 (0.18–1.56) 0.250
EMR versus AFR 0.82 (0.41–1.61) 0.557 n/a
SEAR versus AFR 1.78 (1.13–2.80) 0.013 2.21 (1.23–3.97) 0.008
WPR versus AFR 1.01 (0.61–1.67) 0.971 1.19 (0.63–2.22) 0.590
High versus low HIV prevalence in general population 0.72 (0.43–1.20) 0.210 0.87 (0.46–1.66) 0.676
High versus low HIV prevalence in incident TB 1.18 (0.62–2.22) 0.617 1.26 (0.59–2.71) 0.555
Initial screening procedures requiring self-report of signs/symptoms
versus broader initial screening procedures
0.83 (0.63–1.10) 0.190 0.65 (0.45–0.93) 0.020
AFR, African Region; AMR, Region of the Americas; EMR, Eastern Mediterranean Region; n/a, not applicable; SEAR, South-East Asia Region; WPR,
Western Paciﬁc Region.
doi:10.1371/journal.pmed.1002119.t002
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Discussion
Meta-analysis of 56 TB prevalence surveys including 2.2 million participants in 28 countries pro-
vides strong evidence that TB prevalence is higher amongmen than women, with a higher M:F
ratio than that reported for case notification data. The number of prevalent cases per notified case of
smear-positive TB was also higher amongmen than women, adding evidence that menmay be less
likely than women to seek or access care in many settings. Further evidence of men’s barriers to
seeking or accessing care is provided by results showing that men were less likely than women to
participate in prevalence surveys and that relatively fewer prevalent cases were found among men in
surveys that required participants to self-report signs or symptoms in initial screening procedures.
The excess male prevalence observed in surveys conducted between 1953 and 1997 [5] per-
sists in more recent surveys, despite widespread implementation of the DOTS strategy and
interventions against the HIV pandemic that have decreased overall TB prevalence. Regional
summary M:F ratios in the current study were similar to those previously reported for South-
East Asia (3.8 versus 3.2), where sex differences were greatest, and the Western Pacific (1.9 ver-
sus 2.0). However, in the current study, the summary M:F ratio for the African Region was
Fig 5. Random-effects weightedmale-to-female prevalence ratios for bacteriologically positive TB by
age group (n = 19). Analysis includes surveys that report the number of individuals screened and the number
of bacteriologically positive TB cases by sex and age. Horizontal axis shows age groups in years. Vertical
axis shows random-effects weighted M:F ratios in prevalence of bacteriologically positive TB per 100,000
individuals with 95% confidence intervals.
doi:10.1371/journal.pmed.1002119.g005
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twice that previously reported (2.0 versus 1.0), suggesting that sex disparities in TB prevalence
in this region have increased over the past fifty years. The emergence of HIV during this time
has had a substantial impact on TB epidemiology, especially in the African Region. However,
Fig 6. Male-to-female ratios in prevalence-to-notification ratios (n = 34). Analysis includes surveys that report the prevalence of
smear-positive TB by sex and for which corresponding national notification and population data are available. See S2 Table for survey
details and references.
doi:10.1371/journal.pmed.1002119.g006
Sex differences in TB prevalence
PLOSMedicine | DOI:10.1371/journal.pmed.1002119 September 6, 2016 14 / 23
while the prevalence of HIV is slightly higher among women than men [113], this study shows
that the prevalence of TB is higher among men, even in countries with generalised HIV epi-
demics. Men also face a relative disadvantage in accessing and remaining in HIV care [114–
117], and so men’s risk of TB is likely to be further increased as a result of undiagnosed and
untreated HIV co-infection and missed opportunities for TB screening within HIV care.
Comparisons of sex ratios in TB prevalence and notification highlight sex differences in time
to diagnosis and imply that in many settings women are more likely than men to have a timely
TB diagnosis. While these results could be attributed to men seeking care in private facilities and
therefore being less likely to be included in case notification numbers, this explanation would
require that the proportion of men who seek care in the public sector be only two-thirds the pro-
portion of women who seek care in that sector. Instead, there is wider evidence that men are less
well-served than women by health services [118,119]. Within the context of HIV, which has a
similarly lengthy pathway to diagnosis, there is also substantial evidence that men experience
greater attrition and worse outcomes [114–117]. Men are less likely than women to access antire-
troviral therapy, and in many countries this disparity has increased over time [114]. Similar evi-
dence showing men’s disadvantage in the TB care pathway is building [120–122]. Focusing
specifically on access to diagnosis, male TB patients often delay care-seeking longer than female
TB patients [123], and this review adds support that timely entry into the TB care pathway may
be more difficult for men than women in many settings.
Lower prevalence survey participation among men and evidence of lower M:F prevalence
ratios in studies that require individuals to self-report signs or symptoms of TB in initial screen-
ing procedures imply that symptom screening in community-based active case finding may be a
less effective tool for identifying TB disease in men than women. It is not known whether this is
due to men refusing to report symptoms or whether the sub-clinical phase of disease may be lon-
ger for men [124]. Further investigation is needed to examine men’s acceptance of screening and
reporting of symptoms, even when barriers related to visiting a healthcare facility are removed.
Findings from this review suggest that case detection efforts, whilst not ignoring women,
should be greatly strengthened for men. This will require a detailed understanding of the barri-
ers that men face in accessing care. Previous studies have highlighted factors such as loss of
income and financial barriers, as well as stigma, that affect men’s healthcare decisions
[125,126]. Care-seeking decisions are further influenced by perceptions of masculinity that dis-
courage admission of illness, and systems of care that take away men’s sense of control and
leave feelings of inadequacy [127,128]. Interventions to improve case detection among men
must recognise and address these barriers. Healthcare providers should be sensitive to men’s
needs and consider offering dedicated clinic times and outreach services for men. TB diagnos-
tic services that incorporate men’s peer networks or workplaces to promote wellness and
reduce stigma may also be effective. In South Africa, a men-only after-hours clinic situated
close to a transport hub has been effective in improving men’s uptake of HIV testing and
adherence to antiretroviral therapy [129]. Comparable opportunities for TB strategies that
offer convenient access to care while maintaining men’s sense of control should be explored.
This review summarises evidence on sex ratios in TB prevalence from a large number of
prevalence surveys across geographic regions, an approach which introduces a number of
potential sources of bias. Surveys varied greatly in their methodology, particularly in screening
criteria and case definitions, and levels of participation varied within and between studies.
However, over 84% of the surveys in the analyses had low to moderate risk of bias.
Prevalence as a measure of disease burden has limitations as it provides an estimate at a sin-
gle point in time and cannot distinguish between disease as a result of recent infection and dis-
ease from reactivation, limiting understanding of current transmission. Comparing the rate of
prevalent cases to notified cases is a crude measurement, especially comparing all surveys to
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national case notification rates, regardless of study setting. Stratifying by age and rural or
urban setting would improve P:N ratios; however, data on these characteristics were not avail-
able at the time of analysis. Prevalence data by sex and HIV status were too infrequently avail-
able to be reported here. To our knowledge, no surveys that conducted drug susceptibility
testing reported the results of those analyses by sex, so it is not possible to comment on whether
the sex differences reported here are also relevant to drug-resistant TB. Given the significant
sex differences reported in prevalence, future surveys should analyse and report all results by
sex to facilitate greater understanding of the relationship between gender and TB.
Men have a higher prevalence of TB and, in many settings, remain infectious in the commu-
nity for a longer period of time than women. Men are therefore likely to generate a greater
number of secondary infections than women, and social mixing patterns have suggested that,
as a result, men are responsible for the majority of infections in men, women, and children
[12]. Addressing men’s burden of disease and disadvantage in TB care is therefore an issue not
only for men’s health but for broader TB prevention and care. Given the compelling evidence
presented here, global discourse and policy on key underserved populations need to include a
focus on men. Recommendations to address issues of gender and TB cannot continue to insist
on addressing the needs of women and girls [130] while ignoring the inequity faced by men
and boys, who carry the higher burden of disease, often with less access to timely diagnosis and
treatment. With a clear need and high burden, improving diagnosis and treatment among men
is essential to achieving the ambitious targets of the End TB Strategy.
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